Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells

Zachary J. Reitman(Broad Institute), Brenton R. Paolella(Broad Institute), Guillaume Bergthold(Roche (Switzerland)), Kristine Pelton(Dana-Farber Cancer Institute), Sarah Becker(Dana-Farber Cancer Institute), Robert T. Jones(Dana-Farber Cancer Institute), Claire Sinai(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Hayley Malkin(Dana-Farber Cancer Institute), Ying Huang(Dana-Farber Cancer Institute), Leslie Grimmet(Dana-Farber Cancer Institute), Zachary T. Herbert(Dana-Farber Cancer Institute), Yu Sun(Dana-Farber Cancer Institute), Jessica L. Weatherbee(Dana-Farber Cancer Institute), John A. Alberta(Dana-Farber Cancer Institute), John Daley(Dana-Farber Cancer Institute), Orit Rozenblatt–Rosen(Broad Institute), Alexandra L. Condurat(Broad Institute), Kenin Qian(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Prasidda Khadka(Dana-Farber Cancer Institute), Rosalind A. Segal(Dana-Farber Cancer Institute), Daphne A. Haas‐Kogan(Dana-Farber Cancer Institute), Mariella G. Filbin(Broad Institute), Mario L. Suvà(Broad Institute), Aviv Regev(Broad Institute), Charles D. Stiles(Dana-Farber Cancer Institute), Mark W. Kieran(Harvard University), Liliana Goumnerova(Boston Children's Hospital), Keith L. Ligon(Broad Institute), Alex K. Shalek(Broad Institute), Pratiti Bandopadhayay(Broad Institute), Rameen Beroukhim(Broad Institute)
Nature Communications
August 19, 2019
Cited by 91Open Access
Full Text

Abstract

Pilocytic astrocytoma (PA), the most common childhood brain tumor, is a low-grade glioma with a single driver BRAF rearrangement. Here, we perform scRNAseq in six PAs using methods that enabled detection of the rearrangement. When compared to higher-grade gliomas, a strikingly higher proportion of the PA cancer cells exhibit a differentiated, astrocyte-like phenotype. A smaller proportion of cells exhibit a progenitor-like phenotype with evidence of proliferation. These express a mitogen-activated protein kinase (MAPK) programme that was absent from higher-grade gliomas. Immune cells, especially microglia, comprise 40% of all cells in the PAs and account for differences in bulk expression profiles between tumor locations and subtypes. These data indicate that MAPK signaling is restricted to relatively undifferentiated cancer cells in PA, with implications for investigational therapies directed at this pathway.


Related Papers